| Variables |
Subjects (129) |
| Receptors |
|
| Age (years) |
43 ± 16 |
| Weight (kg) |
68.1 ± 13.2 |
| Men |
70.5 % (91) |
| Ethnics |
|
| White |
46.5% (60/128) |
| Mulattoes |
36.4% (47/128) |
| Black |
10.8% (14/128) |
| Others |
5.4% (7/128) |
| Co-morbidities |
|
| Diabetes |
13.9% (18) |
| Hypertension |
50.4% (65) |
| Dyslipidemia |
2.3% (3) |
| BPAR |
27.9% (36) |
| Donors |
|
| Age (years) |
44 ± 10 |
| Living donor |
58.7% (74/126) |
| Ethnics |
|
| White |
55.3% (68/123) |
| Mulattoes |
34.1% (42/123) |
| Black |
8.1% (10/123) |
| Others |
3.2% (4/123) |
| Immunosuppression at three-months |
|
| TAC concentration (ng/mL) |
5.9 ± 2.7 |
| MPS dose (g/d) |
1.4 ± 0.2 |
| PRED dose (mg/d) |
5.6 ± 3.0 |
Note: number of individuals in parentheses. TAC: tacrolimus, MPS: mycophenolate
sodium, PRED: prednisone; BPAR: biopsy-confirmed acute rejection |
